메뉴 건너뛰기




Volumn 23, Issue 4, 2007, Pages 359-365

A comparative, placebo-controlled study of prostanoid fluoroprostaglandin- receptor agonists tafluprost and latanoprost in healthy males

Author keywords

[No Author keywords available]

Indexed keywords

AFP 168; LATANOPROST; PLACEBO; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; TAFLUPROST; UNCLASSIFIED DRUG; ANTIHYPERTENSIVE AGENT; EYE DROPS; PROSTAGLANDIN F; PROSTAGLANDIN RECEPTOR;

EID: 35848961012     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.0061     Document Type: Article
Times cited : (46)

References (9)
  • 1
    • 4644343744 scopus 로고    scopus 로고
    • Risk assessment in the management of patients with ocular hypertension
    • Weinreb, R.N., Friedman, D.S., Fechtner, R.D., et al. Risk assessment in the management of patients with ocular hypertension. Am. J. Ophthalmol. 138:458-467, 2004.
    • (2004) Am. J. Ophthalmol , vol.138 , pp. 458-467
    • Weinreb, R.N.1    Friedman, D.S.2    Fechtner, R.D.3
  • 2
    • 3342959178 scopus 로고    scopus 로고
    • 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma
    • Aim, A., Schoenfelder, J., and McDermott, J. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch. Ophthalmol. 122:957-965, 2004.
    • (2004) Arch. Ophthalmol , vol.122 , pp. 957-965
    • Aim, A.1    Schoenfelder, J.2    McDermott, J.A.3
  • 3
    • 0036669288 scopus 로고    scopus 로고
    • The effect of latanoprost on intraocular pressure during 2 years of treatment
    • Hedman, K., Watson, P.G., and Aim, A. The effect of latanoprost on intraocular pressure during 2 years of treatment. Surv. Ophthalmol. 47(Suppl. 1):S65-S76, 2002.
    • (2002) Surv. Ophthalmol , vol.47 , Issue.SUPPL. 1
    • Hedman, K.1    Watson, P.G.2    Aim, A.3
  • 4
    • 0034053613 scopus 로고    scopus 로고
    • Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys
    • Res. 13
    • Prota, G., Vincensi, M.R., Napolitano, A., et al. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys. Pig. Cell Res. 13: 147-150, 2000.
    • (2000) Pig. Cell , pp. 147-150
    • Prota, G.1    Vincensi, M.R.2    Napolitano, A.3
  • 5
    • 1842450742 scopus 로고    scopus 로고
    • A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost
    • Chiba, T., Kashiwagi, K., Ishijima, et al. A prospective study of iridial pigmentation and eyelash changes due to ophthalmic treatment with latanoprost. Jpn. J. Ophthalmol. 48:141-147, 2004.
    • (2004) Jpn. J. Ophthalmol , vol.48 , pp. 141-147
    • Chiba, T.1    Kashiwagi, K.2    Ishijima3
  • 6
    • 22744449443 scopus 로고    scopus 로고
    • Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes
    • Chou, S.Y., Chou, C.K., Kuang, T.M., et al. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes. Eye 19:784-787, 2005.
    • (2005) Eye , vol.19 , pp. 784-787
    • Chou, S.Y.1    Chou, C.K.2    Kuang, T.M.3
  • 7
    • 1342329392 scopus 로고    scopus 로고
    • New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents
    • Nakajima, T., Matsugi, T., Goro, W., et al. New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents. Biol. Pharm. Bull. 26:1691-1695, 2003.
    • (2003) Biol. Pharm. Bull , vol.26 , pp. 1691-1695
    • Nakajima, T.1    Matsugi, T.2    Goro, W.3
  • 9
    • 1342308486 scopus 로고    scopus 로고
    • Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug
    • Takagi, Y., Nakajima, T., Shimazaki, A., et al. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp. Eye Res. 78:767-776, 2004.
    • (2004) Exp. Eye Res , vol.78 , pp. 767-776
    • Takagi, Y.1    Nakajima, T.2    Shimazaki, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.